Cameron Peterson, MD
Physical Medicine & Rehabilitation · Logan, UTNPI 1164604765
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,006 of the $1,311 with a category attached, or 76.7%. 4 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 51.3% of the total. Reporting peaked in 2023 at $932 and has fallen 87.6% since, to $116 in 2025.
Across 22 payments — averaging $59.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$673
- Curonix LLC$474
- Teva Pharmaceuticals USA, Inc.$131
- Shire North American Group Inc$33
What the payments were for
- Travel & lodging$28822%
- Food & beverage$1,00677%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 12 | $673 |
| Curonix LLC | 6 | $474 |
| Teva Pharmaceuticals USA, Inc. | 2 | $131 |
| Shire North American Group Inc | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,311 in reported general payments places this provider in the 70th percentile of 117 physical medicine & rehabilitation providers in Utah.
See all physical medicine & rehabilitation providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 385 | $118,390 |
| JardianceEmpagliflozin | 51 | $17,282 |
| XareltoRivaroxaban | 52 | $14,302 |
| TrulicityDulaglutide | 13 | $11,437 |
| EntrestoSacubitril/Valsartan | 29 | $10,947 |
| LinzessLinaclotide | 12 | $7,656 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $5,688 |
| LokelmaSodium Zirconium Cyclosilicate | 15 | $5,461 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,140 |
| JanuviaSitagliptin Phosphate | 16 | $4,740 |
| FarxigaDapagliflozin Propanediol | 15 | $4,638 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $4,389 |
| Incruse ElliptaUmeclidinium Bromide | 20 | $3,715 |
| Atorvastatin Calcium | 227 | $3,479 |
| MyrbetriqMirabegron | 13 | $3,417 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Logan
- Ammon HillsLogan$8K
- Morgan CarlsonLogan$2K
- Jonathan SwensonLogan$1K
- Scott AdelmanPark City$143K
- Judith GoochSlc$43K
- Colby BealSt George$25K
- Stephen AndersonBountiful$11K
- Timothy GrangeSalt Lake City$11K
- Matthew IrvinSt George$9K
- Steven EdgleySalt Lake City$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.